H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 47 950 KRW 1.27% Market Closed
Market Cap: 1.4T KRW

Operating Margin

9.4%
Current
Improving
by 1%
vs 3-y average of 8.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.4%
=
Operating Income
₩95.2B
/
Revenue
₩1T

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.4%
=
Operating Income
₩95.2B
/
Revenue
₩1T

Peer Comparison

Country Company Market Cap Operating
Margin
KR
HK Inno.N Corp
KOSDAQ:195940
1.4T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
273.9B USD
Loading...
CH
Novartis AG
SIX:NOVN
219.6B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146.9B USD
Loading...
No Stocks Found

Market Distribution

Higher than 79% of companies in Korea
Percentile
79th
Based on 2 615 companies
79th percentile
9.4%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

HK Inno.N Corp
Glance View

Market Cap
1.4T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
70 407.16 KRW
Undervaluation 32%
Intrinsic Value
Price
H
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
9.4%
=
Operating Income
₩95.2B
/
Revenue
₩1T
What is HK Inno.N Corp's current Operating Margin?

The current Operating Margin for HK Inno.N Corp is 9.4%, which is above its 3-year median of 8.4%.

How has Operating Margin changed over time?

Over the last 3 years, HK Inno.N Corp’s Operating Margin has increased from 7.3% to 9.4%. During this period, it reached a low of 6.2% on Dec 31, 2022 and a high of 10.3% on Mar 31, 2025.

Back to Top